**Question:** In which of the following types of breast carcinoma, would you consider biopsy of opposite breast?

A. Invasive Ductal Carcinoma (IDC)
B. Invasive Lobular Carcinoma (ILC)
C. Ductal Carcinoma in situ (DCIS)
D. Phyllodes Tumor

**Correct Answer: B. Invasive Lobular Carcinoma (ILC)**

**Core Concept:**
Invasive breast cancer refers to malignant cells that have invaded the surrounding tissues beyond the site of origin, whereas ductal carcinoma in situ (DCIS) is confined to the milk ducts and lobules without invasion. Breast cancer can be classified into various subtypes based on histopathological and molecular features. Invasive Lobular Carcinoma (ILC) is a type of invasive breast cancer that originates from the lobules and spreads through the milk ducts, making it more likely to involve the contralateral (opposite) breast compared to other types.

**Why the Correct Answer is Right:**
The correct answer, Invasive Lobular Carcinoma (ILC), is chosen because of its unique characteristics. Invasive lobular carcinomas are more likely to invade the surrounding tissues through the milk ducts, leading to a higher risk of contralateral (opposite) breast involvement. This is in contrast to other types of invasive breast cancer, such as Invasive Ductal Carcinoma (IDC), which typically spreads through the bloodstream or lymphatic system and is less likely to involve the opposite breast.

**Why Each Wrong Option is Incorrect:**

A. Invasive Ductal Carcinoma (IDC): While IDC is a common type of invasive breast cancer, it typically spreads through the bloodstream and lymphatic system, making contralateral breast involvement less common.

B. Invasive Lobular Carcinoma (ILC) and Ductal Carcinoma in Situ (DCIS): These two options are not correct because ILC has a higher risk of contralateral involvement due to its ductal invasion, while DCIS is confined to the ducts and not known for contralateral involvement.

C. Phyllodes Tumor: Phyllodes tumors are benign fibroepithelial tumors and are not related to invasive breast cancer, making this option incorrect.

**Clinical Pearl:**
It is essential to consider the possibility of contralateral breast involvement in cases of Invasive Lobular Carcinoma (ILC) and Ductal Carcinoma in Situ (DCIS), especially when evaluating a patient with a history of breast cancer, as these types can have a higher risk of contralateral breast involvement. If a patient presents with a new breast lump, it is crucial to consider the possibility of either ILC or DCIS, as both are known for contralateral breast involvement.